Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastoma.
Kosuke TakigawaNobuhiro HataYuhei MichiwakiAkio HiwatashiHajime YonezawaDaisuke KugaRyusuke HataeYuhei SangatsudaYutaka FujiokaYusuke FunakoshiRyosuke OtsujiAki SakoOsamu TogaoTakashi YoshiuraKoji YoshimotoMasahiro MizoguchiPublished in: Journal of neuro-oncology (2021)
Early response during BEV-containing chemoradiation can be a predictive indicator of patient outcome in unresectable nd-GBM.